Much of the economic burden in melanoma screening results from biopsies and excisions of benign lesions, especially in patients with multiple melanocytic nevi. The clinical morphologic criteria summarized by the ABCD rule (asymmetry, border irregularity, color variegation, and diameter >6 mm) are not useful in assessing nevi in these patients because many of their benignlesions have positive ABCD features. Dermoscopy has been shown to reduce the number of unnecessary excisions in melanoma screening
1,2; however, irregular dermoscopic features are noted in numerous lesions among patients with multiple nevi, and unnecessary biopsies and excisions are still performed. More reliable screening strategies are needed to improve melanoma screening performance in this patient population.